Patents by Inventor Suzy Charbit

Suzy Charbit has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050119298
    Abstract: The invention relates to enantiomer (?) of tentoprazole. The inventive enantiomer (?) of tenatoprazole, or (?)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfonyl]imidazol[4,5-b]pyridine exhibits improved pharmacokinetic properties which make it possible to use a once a day posology of a drug for relevant indications. Said invention can be used for curing digestive pathologies.
    Type: Application
    Filed: December 16, 2003
    Publication date: June 2, 2005
    Inventors: Avraham Cohen, Suzy Charbit, Francois Schutze, Herve Ficheux, Michel Homerin, Alain Taccoen
  • Publication number: 20040059136
    Abstract: The invention concerns novel flavone and isoflavone derivatives of formulae (Ia) and (Ib) wherein: X represents a group of formula —COOR, or —PO(OR)2; R represents a hydrogen atom or an alkaline or alkaline-earth metal, or a lower alkyl group; R1 represents a hydroxy group, a lower alkoxy group or an acyloxy group; R2 and R3, identical or different, represent a hydrogen or halogen atom, or a trifluoromethyl group, a trichloromethyl group, a hydroxy group, an alkoxy group or an acyloxy group comprising 1 to 5 carbon atoms, or R2 and R3 can combine to form an alkylene dioxy group. The invention is useful for rheumatic diseases.
    Type: Application
    Filed: October 3, 2003
    Publication date: March 25, 2004
    Inventors: Jean-Pierre Gesson, Nadia Fonteneau, Martine Mondon, Suzy Charbit, Herve Ficheux, Francois Schutze
  • Patent number: 6610750
    Abstract: A method of treating osteoarthritis, which is effective not only at targeting the symptoms of the disease, but also in interrupting, preventing, and controlling cartilage destruction, to thereby favorably alter the course of the disease, comprising the administration of an effective amount of rhein or a rhein derivative, preferably diacerein, either alone or in combination with at least one member selected from the group consisting of analgesics, antipyretics, cortico-steroids, anti-inflammatory agents, cyclooxygenase-2 inhibitors, and inflammatory cytokine inhibitors, to a subject in need of such treatment.
    Type: Grant
    Filed: September 15, 2000
    Date of Patent: August 26, 2003
    Assignee: Laboratoires Negma
    Inventors: Suzy Charbit, Francois Schutze, Alain Taccoen, Jean-Pierre Pelletier, Diego Provvedini
  • Publication number: 20020128317
    Abstract: An enteral food composition for clinical or dietary use, comprises, in addition to carbohydrates and proteins or their hydrolysates the following components or their nutritional equivalents, per daily dosage: methionine (0.6-7 g), cysteine (0.5-2.5 g), folic acid (0.4-8 mg), pyridoxal (vitamin B 6) (3-20 mg), zinc (18-120 mg) and at least 400 kcal energy in the form of carbohydrates. These amounts are well above the Recommended Daily Allowance (RDA) values. Further preferred components include lecithin, cvanocobalamine, betaine and magnesium, as well as transsulfuration metabolites, ATP enhancers and antioxidants.
    Type: Application
    Filed: January 23, 2001
    Publication date: September 12, 2002
    Applicant: Laboratories NEGMA
    Inventors: Suzy Charbit, Francois Schutze, Alain Taccoen, Jean-Pierre Pellctier